Literature DB >> 10461021

Vitamin-D receptor genotype does not predict bone mineral density, bone turnover, and growth in prepubertal children.

G I Baroncelli1, G Federico, S Bertelloni, C Ceccarelli, D Cupelli, G Saggese.   

Abstract

We examined whether the polymorphism for BsmI restriction enzyme in the vitamin-D receptor (VDR) gene influenced radial (distal third) and lumbar (L2-L4) bone mineral density (BMD), phospho-calcium metabolism (calcium, phosphate, intact parathyroid hormone, 25-hydroxyvitamin D, and 1,25-dihydroxyvitamin D), biochemical markers of bone formation (osteocalcin and carboxy-terminal propeptide of type-I procollagen) and bone resorption (carboxy-terminal telopeptide of type-I collagen and urinary cross-linked N-telopeptides of type I collagen), insulin-like growth factor I and insulin-like growth factor-binding protein 3, and growth in 209 healthy prepubertal children (112 males and 97 females) aged 7.1-10.0 years. Genotype frequencies were BB 19%, Bb 46%, and bb 35% in the pooled group of children. Clinical findings, dietary calcium intake, calcium density, and physical activity rate were not different (p NS) among the VDR genotypes. Radial BMD, lumbar BMDarea and lumbar BMD adjusted for the apparent bone volume (BMDvolume), and all the biochemical parameters did not differ (p NS) in relation to the VDR genotype. In conclusion, our data show that polymorphism for BsmI restriction enzyme in the VDR gene is not associated with radial and lumbar BMD, parameters of phospho-calcium metabolism and bone turnover, growth hormone-dependent growth factors, and growth in prepubertal children.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10461021     DOI: 10.1159/000023348

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  5 in total

1.  Vitamin D receptor gene variability as a factor influencing bone mineral density in pediatric patients.

Authors:  Elżbieta Jakubowska-Pietkiewicz; Wojciech Młynarski; Izabela Klich; Wojciech Fendler; Danuta Chlebna-Sokół
Journal:  Mol Biol Rep       Date:  2012-03-16       Impact factor: 2.316

2.  Pharmacogenetic risk factors for altered bone mineral density and body composition in pediatric acute lymphoblastic leukemia.

Authors:  Mariël L te Winkel; Robert D van Beek; Sabine M P F de Muinck Keizer-Schrama; André G Uitterlinden; Wim C J Hop; Rob Pieters; Marry M van den Heuvel-Eibrink
Journal:  Haematologica       Date:  2009-12-16       Impact factor: 9.941

3.  Vitamin D Status and Bone Mineral Density in Obese Children with Nonalcoholic Fatty Liver Disease.

Authors:  Eun Jae Chang; Dae Yong Yi; Hye Ran Yang
Journal:  J Korean Med Sci       Date:  2015-11-30       Impact factor: 2.153

Review 4.  Association between vitamin D receptor BsmI polymorphism and bone mineral density in pediatric patients: A meta-analysis and systematic review of observational studies.

Authors:  Li Bao; Mingzhi Chen; Yong Lei; Zemin Zhou; Huiping Shen; Feng Le
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

5.  Vitamin D Status in Russian Children and Adolescents: Contribution of Genetic and Exogenous Factors.

Authors:  Elena I Kondratyeva; Irina N Zakharova; Natalya A Ilenkova; Leonid Ya Klimov; Nika V Petrova; Aisa E Zodbinova; Elena K Zhekaite; Vladimir V Chikunov; Svetlana V Dolbnya; Anna Yu Voronkova; Victoria D Sherman; Elena V Loshkova; Yuliya L Melyanovskaya; Roman M Budzinskiy; Victoria A Kuryaninova; Sergey I Kutsev
Journal:  Front Pediatr       Date:  2020-11-19       Impact factor: 3.418

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.